A Phase 1/2a Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION717 in Patients with Prion Disease
Brief description of study
The purpose of this research study is to evaluate whether ION717 is safe, well-tolerated, and determine how it affects and processes in the human body.
Clinical Study Identifier: s23-00627
ClinicalTrials.gov Identifier: NCT06153966
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
